Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 1
2013 1
2014 3
2015 1
2016 4
2018 1
2019 3
2020 3
2021 6
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer.
Pippione AC, Kovachka S, Vigato C, Bertarini L, Mannella I, Sainas S, Rolando B, Denasio E, Piercy-Mycock H, Romalho L, Salladini E, Adinolfi S, Zonari D, Peraldo-Neia C, Chiorino G, Passoni A, Mirza OA, Frydenvang K, Pors K, Lolli ML, Spyrakis F, Oliaro-Bosso S, Boschi D. Pippione AC, et al. Among authors: peraldo neia c. Eur J Med Chem. 2024 Mar 15;268:116193. doi: 10.1016/j.ejmech.2024.116193. Epub 2024 Feb 7. Eur J Med Chem. 2024. PMID: 38364714 Free article.
Development and validation of a clinical decision support system based on PSA, microRNAs, and MRI for the detection of prostate cancer.
Mazzetti S, Defeudis A, Nicoletti G, Chiorino G, De Luca S, Faletti R, Gatti M, Gontero P, Manfredi M, Mello-Grand M, Peraldo-Neia C, Zitella A, Porpiglia F, Regge D, Giannini V. Mazzetti S, et al. Among authors: peraldo neia c. Eur Radiol. 2024 Jan 4. doi: 10.1007/s00330-023-10542-1. Online ahead of print. Eur Radiol. 2024. PMID: 38177618
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).
Lombardi P, Aimar G, Peraldo-Neia C, Bonzano A, Depetris I, Fenocchio E, Filippi R, Quarà V, Milanesio M, Cavalloni G, Gammaitoni L, Basiricò M, Cagnazzo C, Ostano P, Chiorino G, Aglietta M, Leone F. Lombardi P, et al. Among authors: peraldo neia c. Oncol Rep. 2023 Feb;49(2):31. doi: 10.3892/or.2022.8468. Epub 2022 Dec 23. Oncol Rep. 2023. PMID: 36562382 Free PMC article.
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA.
Mello-Grand M, Bruno A, Sacchetto L, Cristoni S, Gregnanin I, Dematteis A, Zitella A, Gontero P, Peraldo-Neia C, Ricotta R, Noonan DM, Albini A, Chiorino G. Mello-Grand M, et al. Among authors: peraldo neia c. Front Oncol. 2021 Nov 19;11:769158. doi: 10.3389/fonc.2021.769158. eCollection 2021. Front Oncol. 2021. PMID: 34868998 Free PMC article.
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
Correnti M, Cappon A, Pastore M, Piombanti B, Lori G, Oliveira DVPN, Munoz-Garrido P, Lewinska M, Andersen JB, Coulouarn C, Sulpice L, Peraldo Neia C, Cavalloni G, Quarta S, Biasiolo A, Fassan M, Ramazzotti M, Parri M, Recalcati S, di Tommaso L, Campani C, Invernizzi P, Torzilli G, Marra F, Pontisso P, Raggi C. Correnti M, et al. Among authors: peraldo neia c. Liver Int. 2022 Jan;42(1):233-248. doi: 10.1111/liv.15049. Epub 2021 Sep 16. Liver Int. 2022. PMID: 34478594 Free PMC article.
Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing.
Galluzzo A, Gallo S, Pardini B, Birolo G, Fariselli P, Boretto P, Vitacolonna A, Peraldo-Neia C, Spilinga M, Volpe A, Celentani D, Pidello S, Bonzano A, Matullo G, Giustetto C, Bergerone S, Crepaldi T. Galluzzo A, et al. Among authors: peraldo neia c. ESC Heart Fail. 2021 Aug;8(4):2907-2919. doi: 10.1002/ehf2.13371. Epub 2021 May 2. ESC Heart Fail. 2021. PMID: 33934544 Free PMC article.
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
Peraldo-Neia C, Ostano P, Mello-Grand M, Guana F, Gregnanin I, Boschi D, Oliaro-Bosso S, Pippione AC, Carenzo A, De Cecco L, Cavalieri S, Micali A, Perrone F, Averono G, Bagnasacco P, Dosdegani R, Masini L, Krengli M, Aluffi-Valletti P, Valente G, Chiorino G. Peraldo-Neia C, et al. Cell Oncol (Dordr). 2021 Apr;44(2):357-372. doi: 10.1007/s13402-020-00571-z. Epub 2020 Nov 19. Cell Oncol (Dordr). 2021. PMID: 33211282
27 results